151 related articles for article (PubMed ID: 36524316)
21. Acetyl-L-carnitine for patients with hepatic encephalopathy.
Martí-Carvajal AJ; Gluud C; Arevalo-Rodriguez I; Martí-Amarista CE
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011451. PubMed ID: 30610762
[TBL] [Abstract][Full Text] [Related]
22. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
23. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
[TBL] [Abstract][Full Text] [Related]
24. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
25. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
26. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
27. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis.
Kwok CS; Krupa L; Mahtani A; Kaye D; Rushbrook SM; Phillips MG; Gelson W
Biomed Res Int; 2013; 2013():295153. PubMed ID: 24222902
[TBL] [Abstract][Full Text] [Related]
28. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
Shen YC; Chang YH; Fang CJ; Lin YS
Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
[TBL] [Abstract][Full Text] [Related]
29. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
Dănulescu RM; Stanciu C; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
[TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure.
Siu JT; Nguyen T; Turgeon RD
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012123. PubMed ID: 33294991
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
33. Incidence of spontaneous bacterial peritonitis among asymptomatic cirrhosis patients undergoing outpatient paracentesis: a systematic review and meta-analysis.
Alotaibi A; Almaghrabi M; Ahmed O; Rodrigues D; Iansavichene A; Puka K; Gandhi R; Sey M; Patel K; Brahmania M
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e851-e857. PubMed ID: 34432678
[TBL] [Abstract][Full Text] [Related]
34. Early Paracentesis in High-Risk Hospitalized Patients: Time for a New Quality Indicator.
Rosenblatt R; Tafesh Z; Shen N; Cohen-Mekelburg S; Kumar S; Lucero C; Brown RS; Verna E; Fortune B; Jesudian A
Am J Gastroenterol; 2019 Dec; 114(12):1863-1869. PubMed ID: 31688022
[TBL] [Abstract][Full Text] [Related]
35. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
[TBL] [Abstract][Full Text] [Related]
36. Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.
Ashour AA; Atta MA; Sadek KW; Obaid KR; Ashour MA; Ashour A; Danjuma MI; Doi SA; ElZouki AN
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):479-486. PubMed ID: 32976190
[TBL] [Abstract][Full Text] [Related]
37. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites.
Gaetano JN; Micic D; Aronsohn A; Reddy G; Te H; Reau NS; Jensen D
J Gastroenterol Hepatol; 2016 May; 31(5):1025-30. PubMed ID: 26642977
[TBL] [Abstract][Full Text] [Related]
38. Management of uninfected and infected ascites in cirrhosis.
Solà E; Solé C; Ginès P
Liver Int; 2016 Jan; 36 Suppl 1():109-15. PubMed ID: 26725907
[TBL] [Abstract][Full Text] [Related]
39. [Spontaneous bacterial peritonitis in the patients with liver cirrhosis].
Jarcuska P; Veselíny E; Orolín M; Takácová V; Hancová M
Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):265-70. PubMed ID: 15672324
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.
Schwabl P; Bucsics T; Soucek K; Mandorfer M; Bota S; Blacky A; Hirschl AM; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T
Liver Int; 2015 Sep; 35(9):2121-8. PubMed ID: 25644943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
